Versions Compared

Version Old Version 1352 New Version 1353
Changes made by

Lucy Marks

Lucy Marks

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

The Analyses & Displays for Hepatotoxicity project within the Safety Analytics Working Group have published a new White Paper!

This White Paper provides recommendations for displaying, summarising and analysing measures of hepatotoxicity in tables, figures and listings (TFLs). The suggested TFLs will have implications for what and how liver-related data should be collected. If the data required to populate these TFLs is not collected, then there may be insufficient information to adequately assess the potential for a drug to cause or contribute to the cause of hepatotoxicity.

...

The Optimizing the Use of Data Standards Working Group has a new project FDA Requests Public Comment on CDISC Dataset-JSON Standard and is calling for volunteers!

The U.S. Food and Drug Administration (FDA) has recently published a Federal Register Notice exploring the potential adoption of CDISC Dataset-JSON v1.1 as a new exchange standard for electronic study data submissions potentially replace the SAS v5 XPORT Transport Format (XPT) in the long term.

The FDA is seeking comments on whether to accept Dataset-JSON for regulatory applications in the future, specifically regarding:

  • The risks and benefits of industry adoption of Dataset-JSON as a new exchange standard.

  • Any integration challenges with existing tools and systems.

PHUSE, given its expertise and commitment to advancing the implementation of data standards within the pharmaceutical industry, and its recent PHUSE/CDISC pilot, is launching a short-term project to collect and synthesize comments from its members on this Federal Register Notice.

Building on the PHUSE/CDISC pilot this is an opportunity to:

  • Influence the future of regulatory data submissions.

  • Share your expertise and perspectives on data standards.

  • Collaborate with fellow PHUSE members on a timely and impactful initiative.

  • Contribute to PHUSE's position on this important topic.

We are seeking volunteers to participate in this project.

The timeline for this project will be relatively short, aligning with the FDA's comment period. We anticipate the main activities to take place during May.

If you are interested in volunteering for this important project and contributing your expertise, please express your interest by completing this Working Group Project Membership Form.

...